BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11499332)

  • 1. Short-duration oral terbinafine for the treatment of tinea pedis in HIV-positive patients.
    Smith S; Houpt K; Rich P; LaMarca A; Weinberg JM; Alferez TS; Atillasoy E; Opper C
    Cutis; 2001 Jul; 68(1 Suppl):30-9. PubMed ID: 11499332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of short-duration oral terbinafine for the treatment of tinea corporis or tinea cruris in subjects with HIV infection or diabetes.
    Rich P; Houpt KR; LaMarca A; Loven KH; Marbury TC; Matheson R; Miller B; Smith S; Wolf J;
    Cutis; 2001 Jul; 68(1 Suppl):15-22. PubMed ID: 11499330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris.
    Lebwohl M; Elewski B; Eisen D; Savin RC
    Cutis; 2001 Mar; 67(3):261-6. PubMed ID: 11270304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety and tolerability of terbinafine for Tinea capitis in children: Brazilian multicentric study with daily oral tablets for 1,2 and 4 weeks.
    Filho ST; Cucé LC; Foss NT; Marques SA; Santamaria JR
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):141-6. PubMed ID: 9784040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Terbinafine versus miconazole in patients with tinea pedis].
    Vermeer BJ; Staats CC; van Houwelingen JC
    Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1605-8. PubMed ID: 8768815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of terbinafine and clotrimazole in treating tinea pedis.
    Evans EG; Dodman B; Williamson DM; Brown GJ; Bowen RG
    BMJ; 1993 Sep; 307(6905):645-7. PubMed ID: 8401048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of terbinafine 1% topical solution used for 1 week compared with 4 weeks clotrimazole 1% topical solution in the treatment of interdigital tinea pedis: a randomized, double-blind, multi-centre, 8-week clinical trial.
    Schopf R; Hettler O; Bräutigam M; Weidinger G; Kaben U; Mayser P; Resl V
    Mycoses; 1999; 42(5-6):415-20. PubMed ID: 10536434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral terbinafine versus griseofulvin in the treatment of moccasin-type tinea pedis.
    Savin RC
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):807-9. PubMed ID: 2229529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of treatment of severe tinea pedis with 1% terbinafine cream in members of the Japanese self-defense forces.
    Noguchi H; Hiruma M; Kawada A
    Mycoses; 1999; 42(7-8):479-84. PubMed ID: 10546490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One week terbinafine 1% cream (Lamisil) once daily is effective in the treatment of interdigital tinea pedis: a vehicle controlled study. LAS-INT-06 Study Group.
    Korting HC; Tietz HJ; Bräutigam M; Mayser P; Rapatz G; Paul C
    Med Mycol; 2001 Aug; 39(4):335-40. PubMed ID: 11556763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of chronic moccasin-type tinea pedis with terbinafine: a double-blind, placebo-controlled trial.
    Savin RC; Zaias N
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):804-7. PubMed ID: 2229528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of one week of oral terbinafine (250 mg/day) with four weeks of treatment with clotrimazole 1% cream in interdigital tinea pedis.
    Barnetson RS; Marley J; Bullen M; Brookman S; Cowen P; Ellis D; Williams T
    Br J Dermatol; 1998 Oct; 139(4):675-8. PubMed ID: 9892913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
    Hamaguchi T; Takiuchi I
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(2):79-83. PubMed ID: 12040364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful 2-week treatment with terbinafine (Lamisil) for moccasin tinea pedis and tinea manuum.
    White JE; Perkins PJ; Evans EG
    Br J Dermatol; 1991 Sep; 125(3):260-2. PubMed ID: 1911319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a 1-week, twice-daily regimen of terbinafine 1% cream in the treatment of interdigital tinea pedis. Results of placebo-controlled, double-blind, multicenter trials.
    Berman B; Ellis C; Leyden J; Lowe N; Savin R; Shupack J; Stiller M; Tschen E; Zaias N; Birnbaum JE
    J Am Acad Dermatol; 1992 Jun; 26(6):956-60. PubMed ID: 1607415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.